Home > Drug Search >
  • company_query: Acerta Pharma
  •   > 
Drug Filter
Category:
chemistry (27) biology (7)
Status:
Approved (3) Phase Ⅲ (3) Phase Ⅱ (21) Phase Ⅰ (7)
Clinical Stage:
Pending (1) Active (18) Discontinued (12)
Bio-Type:
Vaccine (3) Whole antibody (3)
Indication:
Anxiety (1) Bladder cancer (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Depression (1) Gastric cancer (1) Wet age-related macular degeneration (1) Hepatocellular carcinoma (HCC) (1) Insomnia (1) Rabies (1) Major depressive disorder (MDD) (2) Mantle cell lymphoma (MCL) (1) Melanoma (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (2) Gynaecological cancer (1) Ovarian cancer (1) Choriocarcinoma (1) Postherpetic neuralgia (PHN) (1) Postoperative pain (1) Prostate cancer (2) Renal cell carcinoma (2) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Small cell lung cancer (SCLC) (1) Soft tissue sarcoma (1) Solid tumours (2) Type 2 diabetes (1) Head and neck cancer (1) Inhalational anthrax (1) Colorectal cancer (2) Stroke (1) Autistic disorder (1) Biliary cancer (1) Hereditary orotic aciduria (1) B-cell malignancies (1) Mitochondrial myopathies (1) Lymphoblastic leukaemia (1) Glioblastoma (2) Esophagus cancer (1) Graft versus host disease (2) Cerebral edema diabetic ketoacidosis (1) Hipovolemic shock (1) Wilson’s disease (1) Chemotherapy induced poisoning (1) Sciatica (1)
Aprv. Year:
 (1) 2015 (1) 2016 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top